Eli Lilly stock down on Q4 guidance miss - MSN

Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. But the guidance still represents a 45% increase from the same quarter in 2023.


Install CouponFollow Chrome Extension   CouponFollow Extension

5%
OFF

Eli Lilly Stock Down On Q4 Guidance Miss - MSN

3 weeks from now

Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. But the guidance still represents a 45% increase from the same quarter in 2023.

msn.com

6%
OFF

LLY Stock Down On Lower-Than-Expected Sales Guidance For Q4

3 weeks from now

Eli Lilly and Company’s LLY shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth-quarter …

msn.com

5%
OFF

Eli Lilly Cuts Q4 Sales Forecast, But Analyst Remains Bullish On

3 weeks from now

Eli Lilly (LLY) reduced its fourth-quarter sales guidance by 5%, lowering expectations to $13.5 billion. This figure is $400 million below the low end of the company’s prior guidance and ...

msn.com

6%
OFF

Eli Lilly Stock Tumbles After New Forecasts Show Weight-loss Drug …

3 weeks from now

Jan 14, 2025  · Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. …

yahoo.com

03%
OFF

Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion …

3 weeks from now

Jan 14, 2025  · Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks ... Price Action: LLY stock is down 8.03% at …

yahoo.com

5%
OFF

Eli Lilly Shares Down 7.5% As Market Reacts To Slashed Q4 Forecast

3 weeks from now

Jan 14, 2025  · Shares of Eli Lilly are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024.The pharmaceutical giant expects …

yahoo.com

7%
OFF

Eli Lilly Stock Tumbles On Lowered Guidance As Weight-Loss Drug …

3 weeks from now

Jan 14, 2025  · Eli Lilly stock fell on lowered Q4 guidance amid slower-than-expected sales for its Zepbound and Mounjaro weight loss drugs. ... Eli Lilly stock fell more than 7% to 741.22. …

investors.com

$45
OFF

Lilly Provides Update On 2024 Revenue Guidance, Announces 2025 …

3 weeks from now

Jan 14, 2025  · 2024 revenue is expected to be approximately $45.0 billion for the full year, $4.0 billion above the midpoint of first-time 2024 financial guidance. Q4 2024 revenue is expected …

lilly.com

90%
OFF

Why Eli Lilly, Novo Nordisk, And Viking Therapeutics Stocks All …

3 weeks from now

Jan 14, 2025  · Bad news for Eli Lilly (LLY 2.90%) stock dragged down shares of rival companies in the market for GLP-1 ... Eli Lilly noted that in Q4 2024, the "incretin market" (basically, …

fool.com

7%
OFF

Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is The Stock ...

3 weeks from now

Jan 23, 2025  · On Jan. 14, Eli Lilly released its guidance for the fourth quarter of 2024, as well as the full year of 2025. And investors weren't thrilled with the numbers, leading to a 7% drop in …

fool.com

$45
OFF

Eli Lilly Stock Faces Worst Day In Nearly 4 Years On Q4 Weight

3 weeks from now

Eli Lilly Stock Faces Worst Day In Nearly 4 Years On Q4 Weight-Loss Drug Sales Miss, But Retail Bullish On 2025 Projections ... down from its previous range of $45.4 billion-$46 billion and …

msn.com

6%
OFF

Eli Lilly: BofA Says Buy The Dip After Shares Slide On Q4 Miss

3 weeks from now

Eli Lilly and Company (NYSE: LLY) shares slid 6.6% to $744.91, after it said it expects Q4 revenue at $13.5 billion- weaker than street expectations of $14.08 billion. The miss was …

investing.com

6%
OFF

LLY Stock Down On Lower-Than-Expected Sales Guidance For Q4

3 weeks from now

Jan 15, 2025  · Eli Lilly and Company’s LLY shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth …

tradingview.com

3%
OFF

Eli Lilly Recovers Premarket As Analysts Defend Stock After …

3 weeks from now

Jan 15, 2025  · Eli Lilly & Co. (LLY) shares rose 0.3% premarket Wednesday, bouncing slightly after Tuesday's steep 6% plunge — the worst session for the stock in nearly four years. The …

stocktwits.com

8%
OFF

Eli Lily Cuts 2024 Revenue Guidance By $400M, Shares Sink 8%

3 weeks from now

Eli Lilly anticipates full-year worldwide revenue of approximately $45.0 billion in 2024, reflecting a 32% year-over-year growth but falling slightly below the consensus estimate of $45.49 billion.

msn.com

32%
OFF

Going Into Earnings, Is Eli Lilly Stock A Buy, A Sell, Or ... - Morningstar

3 weeks from now

1 day ago  · What to Watch for in Eli Lilly’s Q4 Earnings. ... and we have Lilly’s overall topline guidance for 2025 (32% at the midpoint). ... we believe Eli Lilly’s stock is over-valued …

morningstar.com

6%
OFF

LLY Stock Down On Lower-Than-Expected Sales Guidance For Q4

3 weeks from now

Jan 15, 2025  · Eli Lilly and Company’s (LLY Quick Quote LLY - Free Report) shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 and …

zacks.com

6%
OFF

Eli Lilly Cuts Q4 Sales Forecast: ETFs To Buy On The Dip - Yahoo …

3 weeks from now

Jan 15, 2025  · Eli Lilly and Company LLY dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than-expected …

yahoo.com

$13.02
OFF

Eli Lilly Posts A Huge Earnings Miss. Should Investors Be Worried?

3 weeks from now

Nov 6, 2024  · Another issue for investors is that Eli Lilly adjusted its guidance for the year, now projecting its adjusted EPS to fall within a range of $13.02 and $13.52 (the previous forecast …

fool.com

40%
OFF

Eli Lilly Stock's Correction Brings Opportunity (NYSE:LLY)

3 weeks from now

2 days ago  · Intro & Thesis. Occupying over 40% of a fast-growing weight loss drug market, Eli Lilly and Company (NYSE:LLY) stock has been growing at a CAGR of over 30% since 2015 to …

seekingalpha.com

5%
OFF

Why Eli Lilly (LLY) Stock Is Declining Today - MSN

3 weeks from now

The shares of pharmaceutical giant Eli Lilly (LLY) are falling 5% today after the company preannounced lower-than-expected fourth-quarter revenue. The firm estimated that it had …

msn.com

4%
OFF

Tractor Supply Stock Slides On Narrow Q4 Earnings Miss, Weaker …

3 weeks from now

1 day ago  · Tractor Supply Co. (TSCO) shares are down 6.4% in premarket trading on Thursday after the rural-lifestyle retailer's fourth-quarter earnings just missed Wall Street's expectations …

morningstar.com

$46
OFF

1 Stubborn Cloud And 2 Silver Linings For Eli Lilly Stock

3 weeks from now

Nov 10, 2024  · In the Q3 report, management trimmed its guidance for 2024's revenue to a maximum of $46 billion, just three months after increasing its annual guidance in Q2 to a high …

fool.com

1%
OFF

Tractor Supply's Stock Slides On Narrow Q4 Earnings Miss

3 weeks from now

1 day ago  · Tractor Supply Co. shares are down 5.1% in premarket trading on Thursday after the rural lifestyle retailer's fourth-quarter earnings just missed Wall Street's expectations and the …

morningstar.com

FAQs about Eli Lilly stock down on Q4 guidance miss - MSN Coupon?

Why did Eli Lilly stock drop 66% on Tuesday?

Eli Lilly and Company’s LLY shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth-quarter sales numbers. The company also issued its total revenue guidance for 2025 at the JP Morgan Healthcare Conference. ...

Why are Eli Lilly shares down 76% today?

Shares of Eli Lilly (NYSE:LLY) are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024. The pharmaceutical giant expects only $13.5 billion in revenue for Q4 2024, compared to the consensus estimate of $13.97 billion. ...

Why did Eli Lilly (LLY) stock trade down 6% Tuesday?

Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. ...

Why did Eli Lilly cut its full-year revenue guidance?

However, Eli Lilly recently surprised investors when it cut its full-year revenue guidance ahead of an investor conference after sales of its GLP-1 drugs fell short of expectations. Eli Lilly now expects revenue to be approximately $13.5 billion for its fourth quarter and $45 billion for the full year 2024. ...

Is Eli Lilly's stock correction ending?

Summary I think Eli Lilly and Company's stock correction may be ending as demand for key drugs Zepbound and Mounjaro remains strong, despite recent sales guidance cuts. The company's high valuation multiples are justified by robust growth prospects in FY2025 and FY2026 (likely beyond that as well). ...

Is Eli Lilly stock in trouble?

Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is the Stock in Trouble? Shares of pharmaceutical giant Eli Lilly have been falling in recent months. The company updated its guidance last week, and investors weren't impressed. It could be a tough year for Eli Lilly -- its valuation remains high, and so are expectations. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension